News

The stock is up 28% in the last month. It is up close to 600% in the last year. The software provider has produced phenomenal ...
If one had bought Palantir on Aug. 8, 2022, a $1,000 investment would be worth about $15,700 today. Three years ago, a ...
Except, that future is the present. A company called Recursion Pharmaceuticals (NASDAQ: RXRX) is doing it. Using its access to 65 petabytes' (65 million gigabytes) worth of biological, chemical, and ...